Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection

Azithromycin is a potent macrolide antibiotic with poorly understood antiinflammatory properties. Long-term use of azithromycin in patients with chronic inflammatory lung diseases, such as cystic fibrosis (CF), results in improved outcomes. Paradoxically, a recent study reported that azithromycin us...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Renna, Maurizio, Schaffner, Catherine, Brown, Karen, Shang, Shaobin, Tamayo, Marcela Henao, Hegyi, Krisztina, Grimsey, Neil J., Cusens, David, Coulter, Sarah, Cooper, Jason, Bowden, Anne R., Newton, Sandra M., Kampmann, Beate, Helm, Jennifer, Jones, Andrew, Haworth, Charles S., Basaraba, Randall J., DeGroote, Mary Ann, Ordway, Diane J., Rubinsztein, David C., Floto, R. Andres
Format: Artigo
Jezik:Inglês
Izdano: American Society for Clinical Investigation 2011
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3163956/
https://ncbi.nlm.nih.gov/pubmed/21804191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI46095
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki